Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by ronrydellon Aug 08, 2007 4:58pm
433 Views
Post# 13217743

What history tells us

What history tells usFor people who are diversified investors in both high quality stocks and also some high risk ventures, history tells us when the sentiment is really negative (like several really rude and low quality posters), buying gets better all the time. People who study the science, talk with management on subjects that are proper and legal in this environment and have the capacity to live with something that, even if it doesn't work out, will still have a very rewarding experience buying the stock at these levels. Many of the holders of this stock don't need the big hit at $60, $100 et al. They will be happy with a staged buyout. If buyers were looking at this stock at $30 six months ago, the company is substantially more valuable today then it was then. Reason tells us that $30 is reasonable again, as an early staged initial milestone payment. Money later on can take forms in valuable potential cash equivalents such as warrants, notes et al. My heart goes out to those people with a basis over $25.00 but then nobody forced you to buy. Stocks like this usually pay off for the early discovers of this stock, people who got in a $1.00, $2.00 et al As for me I'll continue to pick the fruit as the prices go lower and increase the amount each time in proportion to the price. This stock has NEVER had any bad press as far as results on their testing. Any reasonable non-vitriolic comments?
Bullboard Posts